首页> 外文期刊>Acta oncologica. >Testing the methodology for a dosimetric end-to-end audit of IMRT/VMAT: results of IAEA multicentre and national studies
【24h】

Testing the methodology for a dosimetric end-to-end audit of IMRT/VMAT: results of IAEA multicentre and national studies

机译:测试IMRT / VMAT的Dosimetric结束审计方法:IAEA多期中心和国家研究的结果

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Introduction: Within an International Atomic Energy Agency (IAEA) co-ordinated research project (CRP), a remote end-to-end dosimetric quality audit for intensity modulated radiation therapy (IMRT)/ volumetric arc therapy (VMAT) was developed to verify the radiotherapy chain including imaging, treatment planning and dose delivery. The methodology as well as the results obtained in a multi-centre pilot study and national trial runs conducted in close cooperation with dosimetry audit networks (DANs) of IAEA Member States are presented. Material and methods: A solid polystyrene phantom containing a dosimetry insert with an irregular solid water planning target volume (PTV) and organ at risk (OAR) was designed for this audit. The insert can be preloaded with radiochromic film and four thermoluminescent dosimeters (TLDs). For the audit, radiotherapy centres were asked to scan the phantom, contour the structures, create an IMRT/VMAT treatment plan and irradiate the phantom. The dose prescription was to deliver 4Gy to the PTV in two fractions and to limit the OAR dose to a maximum of 2.8Gy. The TLD measured doses and film measured dose distributions were compared with the TPS calculations. Results: Sixteen hospitals from 13 countries and 64 hospitals from 6 countries participated in the mul-ticenter pilot study and in the national runs, respectively. The TLD results for the PTV were all within ±5% acceptance limit for the multicentre pilot study, whereas for national runs, 17 participants failed to meet this criterion. All measured doses in the OAR were below the treatment planning constraint. The film analysis identified seven plans in national runs below the 90% passing rate gamma criteria. Conclusion: The results proved that the methodology of the IMRT/VMAT dosimetric end-to-end audit was feasible for its intended purpose, i.e., the phantom design and materials were suitable; the phantom was easy to use and it was robust enough for shipment. Most importantly the audit methodology was capable of identifying suboptimal IMRT/VMAT delivery.
机译:介绍:在国际原子能机构(原子能机构)协调研究项目(CRP)内,开发了一种用于强度调制放射治疗(IMRT)/体积弧治疗(VMAT)的远端到终端剂量审计以验证放射治疗链包括成像,治疗计划和剂量递送。提出了方法论以及在与IAEA成员国的多季度审计网络(DAS)密切合作中进行的多中心试验研究和国家试验中获得的结果。材料和方法:设计含有不规则固体水计划靶体积(PTV)和风险风险(OAR)的剂量仪的固体聚苯乙烯幻像被设计用于此审计。插入件可以预加载着放射刻度膜和四个热辐发光剂量计(TLD)。对于审计,要求放射疗法中心扫描幻影,轮廓轮廓,创建IMRT / VMAT处理计划并照射幻影。剂量处方是将4gs递送两级分数,并将OAR剂量限制在最多2.8gy。将TLD测量剂量和薄膜测量剂量分布与TPS计算进行比较。结果:来自13个国家的十六家医院和6个来自6个国家的64家医院分别参加了MUL-Ticenter试点研究和国家奔跑。 PTV的TLD结果全部在多中心试验研究的±5%验收限制范围内,而对于国家运行,17名参与者未能达到这一标准。 OAR中的所有测量剂量都低于治疗规划约束。电影分析确定了七项国家在90%过渡率伽玛标准下方的运行计划。结论:结果证明,IMRT / VMAT剂量近端审计的方法对于其预期目的是可行的,即幻影设计和材料是合适的;幻影易于使用,它足以发货。最重要的是,审计方法能够识别次优IMRT / VMAT传递。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号